Type 1 Diabetes--Reaping the Rewards of a Targeted Research Investment

Diabetes
Judith E FradkinGriffin P Rodgers

Abstract

The Diabetes Control and Complications Trial (DCCT) precipitated a major research effort to develop new approaches to achieve near-normal glycemic control in real-world settings in people with type 1 diabetes. Toward that end, a unique funding stream from the U.S. Congress-the Special Statutory Funding Program for Type 1 Diabetes Research-has provided nearly $2.5 billion for research into the prevention, cure, and treatment of type 1 diabetes since 1998. This funding generated a targeted, sustained investment in type 1 diabetes research with six specific goals: identifying new therapeutic targets through the understanding of disease etiology and pathogenesis, preventing or reversing the disease, developing cell replacement therapy, improving management and care, preventing or reducing the complications, and attracting new talent and applying new technologies to type 1 diabetes research. This Perspective describes exciting results that have emerged from the investment and further advances on the horizon, including artificial pancreas technologies, new therapies for diabetic retinopathy, and breakthroughs in laboratory production of β-cells. The recent program extension enables us to build on this foundation and pursue key new in...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
May 31, 2002·The New England Journal of Medicine·UNKNOWN Diabetes Prevention Trial--Type 1 Diabetes Study Group
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Sep 29, 2006·The New England Journal of Medicine·A M James ShapiroJonathan R T Lakey
Sep 14, 2007·Pediatric Diabetes·UNKNOWN TEDDY Study Group
Jul 29, 2009·Archives of Internal Medicine·UNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research GroupTrevor J Orchard
Aug 1, 2009·The Journal of Pediatrics·Diana B PetittiUNKNOWN SEARCH for Diabetes in Youth Study Group
Dec 4, 2013·Diabetes Care·Tihamer OrbanUNKNOWN Type 1 Diabetes TrialNet Abatacept Study Group
Feb 20, 2014·Diabetes Care·Jay M SosenkoUNKNOWN Type 1 Diabetes TrialNet and Diabetes Prevention Trial-Type 1 Study Groups
Jun 6, 2014·Diabetes·Jean M LawrenceUNKNOWN SEARCH for Diabetes in Youth Study Group
Jun 17, 2014·The New England Journal of Medicine·Steven J RussellEdward R Damiano
Jun 21, 2014·Cell·Scott A SoleimanpourDoris A Stoffers
Jul 6, 2014·The New England Journal of Medicine·Edwin LiuUNKNOWN TEDDY Study Group
Oct 4, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·A N BalamuruganF B Barton
Oct 11, 2014·Cell·Felicia W PagliucaDouglas A Melton
Jan 7, 2015·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the DCCT/EDIC Research GroupJohn M Lachin
Feb 19, 2015·The New England Journal of Medicine·UNKNOWN Diabetic Retinopathy Clinical Research NetworkRoy W Beck
May 23, 2015·Diabetes Care·Kellee M MillerUNKNOWN T1D Exchange Clinic Network

❮ Previous
Next ❯

Citations

Aug 16, 2016·Critical Care Medicine·Victor M Victor
Aug 20, 2021·Journal of Obstetrics and Gynaecology of India·Brij Mohan GuptaDevi Dayal

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.